MiroBio mirobio.com


MiroBio develops antibodies and variants to stimulate specific immune cell signals, allowing it to harness the natural control mechanisms of the immune system for therapeutic benefit across a range of diseases.

MiroBio develops antibodies and variants to stimulate specific immune cell signals, allowing it to harness the natural control mechanisms of the immune system for therapeutic benefit across a range of diseases.

Company (Alive / Active)

Phone: 01865 618817

Fax:

BioEscalator
Roosevelt Drive
Oxford, OX3 7FZ
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MiroBio $33.3M Oct 7, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MiroBio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors

Competitors

Company Status Description Investors

TetraGenetics

Arlington, Massachusetts, United States
Alive / ActiveTetraGenetics is an entrepreneurial biotech company focused on the discovery of therapeutics for autoimmune disease and pain. The company specializes in recombinant human ion channel protein production using its proprietary TetraExpress system. The company uses proteins as antigens in antibody discovery programs using a wide variety of animal systems. Its purified proteins are also used for structure determination supporting rational design of small molecule drugs.Login to see details

Patents

Title Application Date Patent Date Status
(Patent / Application)